Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Issue : The Pharmaceutical Journal, October 2012

Sort by: Newest first Oldest first A-Z Z-A

  • Pandemrix-narcolepsy data review raises no fresh concerns Subscription

    22 OCT 2012 15:40

    Normal0falsefalsefalse

  • Cartoon people on ladders (Icefields/Dreamstime.com)

    Pharmacy career development needs to be better defined Subscription

    19 OCT 2012 15:08

    Career development within pharmacy needs to be more efficient and effective, the Modernising Pharmacy Careers board has said.

  • Acetazolamide dose for mountain sickness identified Subscription

    19 OCT 2012 15:03

    The minimum effective dose of acetazolamide for the prevention of acute mountain sickness has been identified as 250mg daily in a systematic review of the evidence (online in the BMJ, 18 October 2012).

  • Action or just warm words? Subscription

    19 OCT 2012 13:37

    The Journal

  • Brain (Photosoup/dreamstime.com)

    Psychosis returns when Alzheimer’s patients stop taking risperidone Subscription

    19 OCT 2012 12:51

    Alzheimer’s disease patients who are successfully treated with risperidone for psychosis or agitation-aggression are at an increased risk of relapse following discontinuation of the drug, according to a study published in the NEJM this week (2012; 367:16).

  • Safety first button (Nasir1164/Dreamstime.com)

    Widely backed safety charter supports voicing of concerns Subscription

    19 OCT 2012 12:46

    Individuals must be able to raise concerns relating to health and social care in a just, open and transparent environment, according to the "Speaking up" charter signed by 28 healthcare organisations, including the Royal Pharmaceutical Society.

  • Resources: NIH LiverTox Database Subscription

    19 OCT 2012 10:09

    The National Institutes of Health in the US is launching a free database of evidence-based information for healthcare professionals and researchers studying liver injury associated with prescription and over-the-counter medicines, and herbals and dietary supplements. LiverTox can be accessed through www.livertox.nih.gov.

  • Revalidation for doctors to begin in December Subscription

    19 OCT 2012 9:30

    Revalidation will begin for UK doctors this December, health secretary Jeremy Hunt announced this morning (19 October 2012). Under the proposed system, which will be run by the General Medical Council, every practising doctor will be subject to five-yearly checks to ensure they are up to date and fit to practise.

  • Proposed methadone fee increase not enough, says affected contractor Subscription

    19 OCT 2012 9:25

    Proposed revisions to methadone fees are a move in the right direction but do not go far enough, says Martin Bennett, managing director of Associated Chemists (Wicker) in Sheffield.

  • Pills (janmika/Dreamstime.com)

    Uptake of NICE-approved drugs variable across England Subscription

    19 OCT 2012 9:20

    Varenicline and statins are among six groups of drugs that are used more than expected in the NHS in England, and trastuzumab and prucalopride are among six groups used less (see Panel).

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.